This neonatal exposure to estradiol resulted in a permanent reduction in prostatic growth and activational response to androgens during adulthood, an effect mediated in part through a permanent reduction in AR expression.[19] Exposure to estradiol results in neonatal results in promoting prostate hyperplasia during adulthood. Here, AR is linked to benign prostatic hyperplasia.